Ultra‐early stage lower‐grade gliomas: How can we define and differentiate these easily misdiagnosed gliomas through intraoperative molecular diagnosis

Documenti analoghi

• Immunotherapeutic advances in glioma management: The rise of vaccine‐based approaches
  di: Wireko Andrew Awuah, et al.
  Pubblicazione: (2024)
• Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives
  di: Jiyuan Liu, et al.
  Pubblicazione: (2024)
• Identification and validation of a glycolysis‐related taxonomy for improving outcomes in glioma
  di: Tianshu Ying, et al.
  Pubblicazione: (2024)
• Multicenter integration analysis of TRP channels revealed potential mechanisms of immunosuppressive microenvironment activation and identified a machine learning‐derived signature for improving outcomes in gliomas
  di: Yuntao Li, et al.
  Pubblicazione: (2024)
• NDC80/HEC1 promotes macrophage polarization and predicts glioma prognosis via single‐cell RNA‐seq and in vitro experiment
  di: Weijie Ye, et al.
  Pubblicazione: (2024)